Zobrazeno 1 - 10
of 172
pro vyhledávání: '"Yanjun Zhu"'
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Background Immunotherapy (IO) plus tyrosine kinase inhibitor (TKI) therapy is the first-line recommendation for advanced renal cell carcinoma (RCC), but no biomarker has been approved for it. Annexin A2 (ANXA2) can induce immune escape in tu
Externí odkaz:
https://doaj.org/article/2c762b09099d45d6942ed545c5610751
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTClinical guidelines have recently advised combination therapy involving immunotherapy (IO) and tyrosine kinase inhibitors (TKI) as the first-line therapy approach for advanced renal cell carcinoma (RCC). Nevertheless, there is currently no av
Externí odkaz:
https://doaj.org/article/d649589a5d90421d84ffd55e1e509cc5
Publikováno v:
BMC Urology, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Checkpoint inhibitor immunotherapy plus tyrosine kinase inhibitor (IO/TKI) have been recently recommended as standard first-line therapy for advanced renal cell carcinoma, while no clinical-available biomarker has been applied. Th
Externí odkaz:
https://doaj.org/article/9544146360e845d59aaccdc82888b131
Publikováno v:
Ecology and Evolution, Vol 14, Iss 4, Pp n/a-n/a (2024)
Abstract Acoustic communication plays important roles in the survival and reproduction of anurans. The perception and discrimination of conspecific sound signals of anurans were always affected by masking background noise. Previous studies suggested
Externí odkaz:
https://doaj.org/article/b96596a0150c482a96b26073a4202623
Publikováno v:
Cancer Medicine, Vol 13, Iss 7, Pp n/a-n/a (2024)
Abstract Background In renal cell carcinoma (RCC), no clinically available biomarker has been utilized for checkpoint inhibitor immunotherapy (IO) + tyrosine kinase inhibitor (TKI) combinations. Galectin‐1 overexpression is found in tumors, with po
Externí odkaz:
https://doaj.org/article/34b92b445129434aaa8bcf0930df2070
Publikováno v:
Energy Reports, Vol 9, Iss , Pp 678-686 (2023)
During service, the water wall tube will inevitably corrode due to various corrosive gases such as SO2, HCl, H2S, etc. To prevent the occurrence of tube burst accidents caused by thinning and income-pressure resistance of the water wall tube, it is n
Externí odkaz:
https://doaj.org/article/e8afb774348044348b876a8680bbfbf9
Publikováno v:
IET Computers & Digital Techniques, Vol 17, Iss 3-4, Pp 100-110 (2023)
Abstract In order to explore the mapping recognition of arc welding molten pool characterisation and penetration state, according to the idea of embedded system construction, this article adopts the idea of software and hardware co‐design to find t
Externí odkaz:
https://doaj.org/article/90809581ff7a4eaeb2c55f6390737571
Publikováno v:
Cancer Medicine, Vol 12, Iss 9, Pp 10512-10525 (2023)
Abstract Background Immunotherapy (IO) plus tyrosine kinase inhibitor (TKI) emerged as standard first‐line therapy for advanced renal cell carcinoma (RCC). The heme Oxygenase 1 (HMOX1) pathway is involved in tumor development and treatment resistan
Externí odkaz:
https://doaj.org/article/e83d31f447ba4ce7a65fb406b959409b
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 43, Iss , Pp 100919- (2023)
Background: Immunotherapy plus tyrosine kinase inhibitor (IO-TKI) has become the first-line management for metastatic renal cell carcinoma (RCC), despite the absence of biomarkers. Recently, pyrroline-5-carboxylate reductase 1 (PYCR1) and proline met
Externí odkaz:
https://doaj.org/article/2c0f7d7f78f444e1966b38b7a09ced05
Autor:
Peirong Xu, Sihong Zhang, Bohong Cao, Jiaqi Huang, Yaohui Li, Jiangting Cheng, Wenyao Lin, Jie Cheng, Weijie Chen, Yanjun Zhu, Shuai Jiang, Xiaoyi Hu, Jianming Guo, Hang Wang
Publikováno v:
World Journal of Surgical Oncology, Vol 20, Iss 1, Pp 1-11 (2022)
Abstract Background To assess the impact of malignant cystic renal masses (CRM) rupture on oncologic outcomes. Methods The study included 406 cases with partial nephrectomy (PN) and 17 cases with cyst decortication confirmed as malignant CRM by patho
Externí odkaz:
https://doaj.org/article/3b58b799920f4d37a4486ebd3352c092